Form 4: Gartner Inc. Executive Claire Herkes Reports Stock Transactions
SEC Form 4 Filing
EVP Claire Herkes reports the acquisition and disposal of Gartner Inc. common stock related to restricted stock units.
Summary
- On July 15, 2024, Claire Herkes, EVP of Conferences at Gartner Inc., acquired 394 shares of common stock upon the release of restricted stock units (RSUs).
- These RSUs convert into common stock on a one-for-one basis and vest in four substantially equal annual installments, commencing on July 15, 2021.
- This transaction represents the 2024 installment.
- On July 16, 2024, Ms. Herkes disposed of 183 shares of common stock at a price of $455.02 per share to cover income and payroll withholding taxes.
- Following these transactions, Ms. Herkes beneficially owns 3,053 shares of Gartner Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an executive, with no inherent positive or negative sentiment. It reflects routine compensation practices.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common among publicly traded companies like Gartner Inc.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation and stock ownership adjustments.
Key Dates
| Date | Description |
|---|---|
| 07/15/2021 | Commencement date for the four-year vesting schedule of the Restricted Stock Units (RSUs). |
| 07/15/2024 | Date of RSU release and acquisition of 394 shares of common stock. |
| 07/16/2024 | Date of disposal of 183 shares for tax obligations. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.